Претраживање
Приказ резултата 1-10 од 88
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
(Amer Soc Hematology, Washington, 2008)
Hydroxyurea, a drug widely used for treating myeloproliferative diseases, has also been approved for the treatment of sickle cell disease by raising fetal hemoglobin (HbF). We have shown that nitric oxide (NO) and the ...
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
(Amer Soc Hematology, Washington, 2006)
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP ...
Transcriptional profiling of human erythroid progenitors from g-csf mobilized and nonmobilized peripheral blood
(Ferrata Storti Foundation, Pavia, 2013)
Addition of the degree of bone marrow fibrosis to IPSS in new scoring system improve prediction of survival in primary myelofibrosis
(Ferrata Storti Foundation, Pavia, 2013)
Analysis of cyclical behavior in time series of stock market returns
(Elsevier Science Bv, Amsterdam, 2018)
In this paper we have analyzed scaling properties and cyclical behavior of the three types of stock market indexes (SMI) time series: data belonging to stock markets of developed economies, emerging economies, and of the ...
JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms
(Amer Soc Hematology, Washington, 2019)
Increased energy requirement and metabolic reprogramming are hallmarks of cancer cells. We show that metabolic alterations in hematopoietic cells are fundamental to the pathogenesis of mutant JAK2-driven myeloproliferative ...
Hypoxia inducible genes, erythropoietin and vascular endothelial growth factor expression in renal cell carcinoma
(Ferrata Storti Foundation, Pavia, 2013)
Gene and protein expression analyses of the mtor signaling pathway in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2015)
Predictors of survival in patients with essential thrombocythemia
(Ferrata Storti Foundation, Pavia, 2015)